ArticleJournal for immunotherapy of cancer2025

Comparative efficacy and safety of PSCA CAR-engineered Vδ1 γδ T cells for immunotherapy of pancreatic cancer.

Zhixin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.